NPAS4 has also been shown to enhance autophagic clearance of the total and phosphorylated pools of endogenous Tau protein in primary cortical neurons, implicating NPAS4 as a potential therapeutic target for neurodegenerative tauopathies such as Alzheimer's disease (13). This evidence concerns the gene NPAS4 and early-onset autosomal dominant Alzheimer disease.